NEW York-listed and ASX-listed medical software and device company ResMed has announced it has successfully completed its acquisition of Minnesota-based software company MatrixCare.
The $750 million deal sees ResMed add to its out-of-hospital software-as-a-service (SaaS) offerings and says it will "drive an integrated ecosystem of solutions across these platforms to maintain single-patient records across multiple care settings, generate analytics and insights that can be applied to individuals and whole populations, and streamline processes across the care continuum".
ResMed CEO Mick Farrell said, "ResMed is the world's top tech-driven medical device company, and we are well on our way to being the top provider of out-of-hospital software".
MatrixCare will continue to operate as a standalone business with no immediate changes to management, locations or business processes, Farrell said.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Nov 18
